ANTI-INFLIXIMAB (IFX) ANTIBODIES - ANVISA Registration 10350840430
Access comprehensive regulatory information for ANTI-INFLIXIMAB (IFX) ANTIBODIES in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10350840430 and manufactured by BODITECH MED INC.. The registration is held by BIOSYS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 3 companies making the same product including PROGENIKA BIOPHARMA S.L., BIOSYNEX SA, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
10350840430
25351425025202287
02220795000179
Company Information
Dates and Status
Nov 07, 2022
VIGENTE
09/18/2025 19:00:01
ANTI-INFLIXIMAB (IFX) ANTIBODIES
FamÃlia AFIAS Free Anti-Infliximab
BODITECH MED INC.
10350840427
Oct 27, 2022
ANTI-ADALIMUMAB ANTIBODIES (ADL)
FamÃlia AFIAS Free Anti-Adalimumab
BODITECH MED INC.
10350840429
Nov 07, 2022
INFLIXIMAB (IFX)
FamÃlia AFIAS Infliximab
BODITECH MED INC.
10350840426
Oct 20, 2022
ADALIMUMAB (ADL)
FamÃlia AFIAS Adalimumab
BODITECH MED INC.
10350840428
Oct 27, 2022
ULTRASENSITIVE C-REACTIVE PROTEIN
FamÃlia AFIAS hsCRP
BODITECH MED INC.
10350840462
Nov 04, 2024
ANTICORPOS ANTI-INFLIXIMAB (IFX)
LISA-TRACKER ANTI-INFLIXIMAB
BIOSYNEX SA
10338930315
Jul 22, 2024
ANTICORPOS ANTI-INFLIXIMAB (IFX)
FamÃlia AFIAS Free Anti-Infliximab
BODITECH MED INC.
10350840427
Oct 27, 2022
ANTICORPOS ANTI-INFLIXIMAB (IFX)
Quantum Blue® Anti-Infliximab
Not specified
80102512585
Sep 24, 2020
ANTICORPOS ANTI-INFLIXIMAB (IFX)
PROMONITOR ANTI-IFX
PROGENIKA BIOPHARMA S.L.
80134860239
Jul 03, 2017